Executives On The Move: Clinical VPs Exit Eisai And Pfizer And New Top Hire At Histogen
Executive Summary
Clinical VPs exit Eisai and Pfizer for positions at mRNA product firm CureVac and nanomedicines developer Taiwan Liposome. New chairman and CEO takes the reins at regenerative medicine company Histogen.